July 26, 2012
Taiho Pharmaceutical announced on July 24 that it concluded a license agreement on the same day with Spain’s Faes Farma S.A. on the development and commercialization of bilastine, a novel anti-allergy agent with anti-histamine activity, in Japan. Taiho is set...read more